Notably, these pathways were predominantly enriched in CD63+ populations, supporting the hypothesis that AML-derived exosomes amplify immunomodulatory communication within the bone marrow microenvironment, potentially contributing to leukemic progression. Here, CD63 is linked to acute myeloid leukemia.